US 11931399
Compositions and methods for dengue virus chimeric constructions in vaccines
granted A61KA61K2039/5254A61K2039/70
Quick answer
US patent 11931399 (Compositions and methods for dengue virus chimeric constructions in vaccines) held by Takeda Vaccines, Inc. expires Mon Mar 14 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Takeda Vaccines, Inc.
- Grant date
- Tue Mar 19 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 14 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 29
- CPC classes
- A61K, A61K2039/5254, A61K2039/70, A61K31/7048, A61K31/713